Teva Pharmaceutical Industries Limited’s TEVA stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since the end of October. It achieved the golden cross in mid-September.

Teva Pharmaceutical Industries just saw its fair value estimate nudged higher from about $27.90 to roughly $28.60, as analysts grow more confident in the company’s turnaround story. The discount rate ...

Teva stock climbs past $30 with strong Austedo and Ajovy sales, but shifting Wall Street sentiment may affect its outlook.

For more than two years, the U.S. Federal Trade Commission (FTC) has been taking certain drugmakers to task over their alleged listing of "improper" patents in an FDA registry, a practice the agency ...

Shares of Teva -- a generic-drug maker with a history of losses and high leverage -- have rallied strongly. Pfizer and Merck, which make branded drugs, are financially strong and are rebuilding their ...

A case against the Long Island-based cannabis company Omnium Health was halted on the eve of trial. A judge on Tuesday held off on dropping the matter. By Ashley Southall New York’s beleaguered ...

Gov. Kathy Hochul requested the resignation of the state’s top cannabis official on Monday after the case against a Lindenhurst-based cannabis distributor was withdrawn on the eve of its ...

Gov. Kathy Hochul demanded the resignation of the head of New York’s Office of Cannabis Management following the withdrawal of a case against a Long Island-based company. By Ashley Southall New York’s ...